C07K 7/08
Having 12 to 20 amino acids
Official title: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
C07K7/08 (Having 12 to 20 amino acids) appears on 4,341 US grants and 6,539 published applications in this corpus.
Search patents in C07K- Granted patents
- 4,341
- Published applications
- 6,539
- Assignees
- 2,463
- Inventors
- 10,557
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 6 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 4 | 0 |
| 1989 | 10 | 0 |
| 1990 | 6 | 0 |
| 1991 | 16 | 0 |
| 1992 | 10 | 0 |
| 1993 | 13 | 0 |
| 1994 | 8 | 0 |
| 1995 | 27 | 0 |
| 1996 | 24 | 0 |
| 1997 | 31 | 0 |
| 1998 | 52 | 0 |
| 1999 | 43 | 0 |
| 2000 | 33 | 0 |
| 2001 | 53 | 7 |
| 2002 | 56 | 65 |
| 2003 | 60 | 177 |
| 2004 | 66 | 140 |
| 2005 | 50 | 146 |
| 2006 | 82 | 160 |
| 2007 | 85 | 149 |
| 2008 | 87 | 135 |
| 2009 | 104 | 189 |
| 2010 | 102 | 239 |
| 2011 | 118 | 215 |
| 2012 | 106 | 197 |
| 2013 | 182 | 321 |
| 2014 | 200 | 354 |
| 2015 | 220 | 367 |
| 2016 | 272 | 401 |
| 2017 | 286 | 385 |
| 2018 | 252 | 334 |
| 2019 | 307 | 353 |
| 2020 | 274 | 368 |
| 2021 | 231 | 347 |
| 2022 | 214 | 348 |
| 2023 | 184 | 296 |
| 2024 | 198 | 355 |
| 2025 | 163 | 294 |
| 2026 | 91 | 197 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Antimicrobial peptide with excellent microbial cytoplasm elution effect29 Sep 2026US 12,747,266 B2Cellicon Lab Inc.
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Method for treatment of dry eye comprising applying P55PIK inhibitor22 Sep 2026US 12,741,988 B2Han Yicheng Biological Technology Co, Ltd.
- Therapeutic peptides8 Oct 2026US 2026/0308201 A1Shape Therapeutics Inc.
- Using vefg165 fragments as a novel biomarker of inflammation to diagnose and guide medical care and treatments8 Oct 2026US 2026/0308202 A1Children's Medical Center Corporation
- P53 activator peptidomimetic macrocycles8 Oct 2026US 2026/0308203 A1Agency for Science, Technology and Research
- Neu5gc-lewis a-targeting molecules and uses thereof in cancer1 Oct 2026US 2026/0295060 A1SRI International
- Peptides as selective il-23 receptor inhibitors1 Oct 2026US 2026/0297129 A1Sanofi
Most cited
By later US patents
- Peptide nucleic acids763US 5,539,082 A1996
- Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility543US 5,714,331 A1998
- Zinc finger binding domains for GNN396US 6,140,081 AThe Scripps Research Institute · 2000
- Immunotherapy against several tumors, such as lung cancer, including NSCLC198US 10,071,148 B2Immatics Biotechnologies GmbH · 2018
- Methods and apparatus for detecting nucleic acid polymorphisms185US 6,297,018 B1LJL BioSystems, Inc. · 2001